AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

169.080

-0.710-0.42%

Volume:95.54K

Turnover:16.10M

Market Cap:11.06B

PE:32.10

High:170.790

Open:169.700

Low:165.880

Close:169.790

52wk High:313.284

52wk Low:160.000

Shares:65.40M

Float Shares:65.14M

Volume Ratio:0.39

T/O Rate:0.15%

Dividend:4.30

Dividend Rate:2.54%

EPS(TTM):5.268

EPS(LYR):5.943

ROE:18.15%

ROA:11.28%

PB:5.71

PE(LYR):28.45

Loading ...

Overview Company News Filings

Cochlear Ltd FY26 Underlying Net Profit Is Expected to Be at Lower End of a$435-a$460 Mln Guidance Range

THOMSON REUTERS

DIARY-Australia, New Zealand corporate earnings week ahead

3 ASX-Listed Stocks with International Revenue to Broaden Your Portfolio

Cochlear Expected to Grow Market Share With Implant, Processor Products, Jefferies Says

MT Newswires Live

Cochlear Valuation Check As Nucleus Nexa System Reaches US Veterans Through VA Clinics

Simply Wall St.

Does VA-Wide Access to Nucleus Nexa Transform the Bull Case for Cochlear (ASX:COH)?

Simply Wall St.

Australian Healthcare Stocks Look Primed for M&A -- Market Talk

CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk

Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk

Cochlear’s VA Nexa Rollout Sparks Fresh Look At Whether The Shares Are Undervalued

Simply Wall St.

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

Did VA Access to Nucleus Nexa Implants Just Shift Cochlear's (ASX:COH) Investment Narrative?

Simply Wall St.

Investors Shouldn't Overlook Cochlear's (ASX:COH) Impressive Returns On Capital

Simply Wall St.

Cochlear Ltd. Expands Access to Nucleus Nexa System for US Veterans

Declining Stock and Solid Fundamentals: Is The Market Wrong About Cochlear Limited (ASX:COH)?

Simply Wall St.

BUZZ-Morningstar sees Australia's Cochlear shares as slightly overvalued

Recent 3.4% pullback isn't enough to hurt long-term Cochlear (ASX:COH) shareholders, they're still up 45% over 5 years

Simply Wall St.

Alan Kohler: The grass is always greener on the other side

Risks To Shareholder Returns Are Elevated At These Prices For Cochlear Limited (ASX:COH)

Simply Wall St.

Cochlear Limited (ASX:COH) is favoured by institutional owners who hold 57% of the company

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COH.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":169.08,"timestamp":1776398869601,"preClose":169.79,"halted":0,"volume":95539,"delay":0,"changeRate":-0.004181636138759524,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":5.268067,"marketStatus":"Trading","change":-0.71,"latestTime":"04-17 14:07:59 AEST","open":169.7,"high":170.79,"low":165.88,"amount":16099359,"amplitude":0.028918,"askPrice":169.08,"askSize":10,"bidPrice":168.99,"bidSize":17,"shortable":3,"etf":0,"ttmEps":5.268067,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776405600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":169.79,"dividendRate":0.025432,"openAndCloseTimeList":[[1776384000000,1776405600000]],"volumeRatio":0.394532,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":169.79,"auctionPrice":169.79,"auctionVolume":2632,"auctionTime":1776383946887,"referenceTime":1776335404095,"auction":1,"marketStatus":"盘前竞价","timestamp":1776383946887}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"11.28%","roe":"18.15%","lyrEps":5.943021,"volumeRatio":0.394532,"shares":65398462,"dividePrice":4.3,"high":170.79,"amplitude":0.028918,"preClose":169.79,"low":165.88,"week52Low":160,"pbRate":"5.71","psRate":"4.73","week52High":313.284,"institutionHeld":0,"latestPrice":169.08,"committee":0.259259,"eps":5.268067,"divideRate":0.025432,"volume":95539,"delay":0,"ttmEps":5.268067,"open":169.7,"prevYearClose":257.41,"prevWeekClose":172.1,"prevMonthClose":169.1,"prevQuarterClose":169.1,"fiveDayClose":172.1,"twentyDayClose":170.28,"sixtyDayClose":266.357,"dividendPayoutRate":0.7151245132736365,"dividendGrowthYears":4,"dividendGrowthRate":0.13333333333333333,"fiveYearAvgDividendRate":0.011947843137511144},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"},{"date":"2025-08-15","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755216000000,"name":null,"time":"","dateTimestamp":1755180000000,"actualEps":null},{"date":"2025-03-20","symbol":"COH.AU","amount":2.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-21","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-21","currency":"AUD","dateTimestamp":1742389200000,"payDate":"2025-04-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611182972","title":"Cochlear Ltd FY26 Underlying Net Profit Is Expected to Be at Lower End of a$435-a$460 Mln Guidance Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2611182972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611182972?lang=en_us&edition=fundamental","pubTime":"2026-02-13 04:32","pubTimestamp":1770928379,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nPLX43053D:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609653957","title":"DIARY-Australia, New Zealand corporate earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2609653957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609653957?lang=en_us&edition=fundamental","pubTime":"2026-02-06 09:00","pubTimestamp":1770339600,"startTime":"0","endTime":"0","summary":"DIARY-Australia, New Zealand corporate earnings week aheadFeb 6 (Reuters) - Diary of Australia and New Zealand (.AXJO, .NZ50) corporate earnings for the week ahead AUSTRALIA & NEW ZEALAND EARNINGS Sta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z11DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7006","BK7007","BK7507","BK7130","GQG.AU","GQPIL","BK7165","BK7112","BK7511","BRG.AU","BK7034","TPW.AU","BK7094","AMP.AU","CLW.AU","BK4011","BK7120","BK4135","WBC.AU","PME.AU","ARF.AU","BK7119","COH.AU","CIP.AU","BK7031","IAG.AU","BK7095","CBA.AU","BK7162","BK7506","CSL.AU","EVN.AU","BK7135","BK7005","BK7062","JHX","BK7107","HDN.AU","BK7099","BK7136","BK7049","BK7067","BK7501","NCK.AU","NST.AU","ORG.AU","SGH.AU","BK7508","S32.AU","AGL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137178741","title":"3 ASX-Listed Stocks with International Revenue to Broaden Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1137178741","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137178741?lang=en_us&edition=fundamental","pubTime":"2026-02-04 10:06","pubTimestamp":1770170792,"startTime":"0","endTime":"0","summary":"When considering geographic diversification, many investors' first instinct is to look at a company's headquarters. However, in today's globalized market, the origin of a company's earnings is...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"3 ASX-Listed Stocks with International Revenue to Broaden Your Portfolio","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","CDA.AU","RHC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608817222","title":"Cochlear Expected to Grow Market Share With Implant, Processor Products, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2608817222","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608817222?lang=en_us&edition=fundamental","pubTime":"2026-02-03 10:12","pubTimestamp":1770084744,"startTime":"0","endTime":"0","summary":"Cochlear's  Nexa Implant and Processor is expected to increase the company's market share over at least the medium term, Jefferies said in a Feb. 1 note.A survey of 25 cochlear implant ear, nose, and throat surgeons, all of whom have implanted the Nexa Implant, found that the product demonstrates competitive advantage, which will likely drive market share gains.Most of the respondents also believe that the Nexa Processor offers a competitive advantage in terms of its positive impact on neural health.Respondents expect a median 10% increase in market share for the company in cochlear implants over a three-year period, Jefferies said.The investment advisory firm believes the company is a franchise with an established track record and holds a dominant global market share in the hearing implant industry, which is expected to grow further with upcoming product releases.Jefferies maintained a buy rating on Cochlear and a price target of AU$345.Cochlear shares rose nearly 1% in afternoon trad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605140804","title":"Cochlear Valuation Check As Nucleus Nexa System Reaches US Veterans Through VA Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605140804?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:17","pubTimestamp":1769087861,"startTime":"0","endTime":"0","summary":"What Cochlear’s VA access milestone could mean for shareholders\nCochlear (ASX:COH) has flagged a new chapter for its flagship Nucleus Nexa System. The device is now available to eligible US military veterans through VA clinics nationwide, opening an additional access point in a key healthcare channel.\nSee our latest analysis for Cochlear.\nWhile Cochlear’s A$270.22 share price has seen a 3.44% 1 month share price return, the 90 day share price return of 7.24% and 1 year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-valuation-check-as-nucleus-nexa-system-reaches-us-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-valuation-check-as-nucleus-nexa-system-reaches-us-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NPL.SI","BK7007","BK6100","DCF","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605648184","title":"Does VA-Wide Access to Nucleus Nexa Transform the Bull Case for Cochlear (ASX:COH)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605648184","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605648184?lang=en_us&edition=fundamental","pubTime":"2026-01-21 18:26","pubTimestamp":1768991165,"startTime":"0","endTime":"0","summary":"In January 2026, Cochlear announced that its Nucleus Nexa System, described as the world’s first smart cochlear implant system, is now available to eligible US military veterans through Department of Veterans Affairs clinics nationwide.\nThis VA rollout meaningfully broadens access to Cochlear’s latest upgradeable, memory-enabled and ultra-light processors, underscoring the company’s role in advanced hearing technology for a large, government-backed patient base.\nWe’ll now examine how VA-wide...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/does-va-wide-access-to-nucleus-nexa-transform-the-bull-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/does-va-wide-access-to-nucleus-nexa-transform-the-bull-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604097010","title":"Australian Healthcare Stocks Look Primed for M&A -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604097010","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604097010?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:49","pubTimestamp":1768780140,"startTime":"0","endTime":"0","summary":"2349 GMT - M&A is a theme to watch among Australian healthcare stocks this year, RBC Capital Markets says. It points to low debt levels in the sector. Most companies covered by RBC are likely to have a leverage ratio of 1.5x or lower, analyst Craig Wong-Pan says. \"We believe the mix of new CEOs, low debt levels and challenging conditions could lead to potential M&A in 2026,\" RBC says. ResMed is likely to keep making small bolt-on acquisitions in respiratory care and adjacent markets, while Ansell could target small or medium-sized deals, RBC says. \"CSL has said it will pivot its R&D activities to focus more on development and it could undertake licensing or partnerships for later stage assets,\" it adds.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","SHL.AU","BK4588","XBI","BK4585","LU0128526141.USD","HLS.AU","BK7508","ANN.AU","BK4581","LU0029874061.USD","COH.AU","HCSG","BK7007","CSL.AU","LABU","XLV","BK7113","BK7511","BK7501","BK7067","BK7124","RHC.AU","BK4137","MVF.AU","IDX.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604709039","title":"CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604709039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604709039?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:41","pubTimestamp":1768779660,"startTime":"0","endTime":"0","summary":"2341 GMT - RBC Capital Markets's message to investors in Australian healthcare stocks: Be alert to CEO transition risks. Among companies that have changed leaders in recent months are Ansell, Sonic Healthcare, Integral Diagnostics and Monash IVF. \"The appointments of new CEOs follow long tenure periods under the previous management, and therefore we see possibilities for a combination of strategy resets, asset impairments, and 'kitchen sinking' guidance,\" says analyst Craig Wong-Pan. There could be operational disruptions from the management changes. Also, some managers who missed out on the CEO position could leave, RBC says. \"We also note there have been a number of new CFOs, including at CSL, Ramsay Health Care and Healius,\" it adds. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","ISBC","ANN.AU","HLS.AU","COH.AU","BK7508","BK7007","BK4588","IDX.AU","LU0128526141.USD","BK4585","BK7509","XBI","BK7511","XLV","RHC.AU","BK7124","BK4581","BK4211","BK7126","BK7113","HCSG","MVF.AU","SHL.AU","LU0029874061.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604970907","title":"Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604970907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604970907?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:40","pubTimestamp":1768779600,"startTime":"0","endTime":"0","summary":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603606575","title":"Cochlear’s VA Nexa Rollout Sparks Fresh Look At Whether The Shares Are Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2603606575","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603606575?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:25","pubTimestamp":1768465515,"startTime":"0","endTime":"0","summary":"Cochlear’s VA access expansion and what it might mean for shareholders\nCochlear (ASX:COH) recently made its Nucleus Nexa cochlear implant system available to eligible US military veterans at VA clinics nationwide, a move that widens access and puts a spotlight on its hearing technology offering.\nSee our latest analysis for Cochlear.\nThe Nucleus Nexa news comes after a period where short term share price momentum has softened. A 90 day share price return of a 6.38% decline contrasts with a 5...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlears-va-nexa-rollout-sparks-fresh-look-at-whether-the-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlears-va-nexa-rollout-sparks-fresh-look-at-whether-the-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603164976","title":"iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2603164976","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603164976?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:03","pubTimestamp":1768395780,"startTime":"0","endTime":"0","summary":"ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc.,creatorofiotaSOFT, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration  510 clearance for expanded pediatric use of itsiotaSOFT Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted cochlear implantation for school-aged children.The iotaSOFT Robotic-Assisted Cochlear Implant Insertion System advances surgery beyond the limits of the human hand with slow, consistent, and controlled electrode insertion to preserve delicate intracochlear structures. Shown with the drive unit guiding the array, iotaSOFT is FDA cleared for patients 4 years and older, expanding access as fewer than 5% of 60M eligible patients worldwide receive implants.A close-up view of the iotaSOFT Robotic-Assisted Cochlear Implant Insertion System. The system is FDA cleared for patients four years of age ","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2861279/iotaMotion_Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861279/iotaMotion_Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/iotamotion-receives-fda-clearance-for-expanded-pediatric-use-of-iotasoft-robotic-assisted-cochlear-implant-insertion-system-302660715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603572973","title":"Did VA Access to Nucleus Nexa Implants Just Shift Cochlear's (ASX:COH) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603572973","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603572973?lang=en_us&edition=fundamental","pubTime":"2026-01-13 08:28","pubTimestamp":1768264095,"startTime":"0","endTime":"0","summary":"In January 2026, Cochlear announced that its Nucleus® Nexa® System, described as the world's first smart cochlear implant with upgradeable firmware, internal memory and all-day battery life, is now available to eligible US military veterans through VA clinics nationwide.\nThis rollout extends Cochlear's most advanced hearing technology to a large, clinically complex patient group, potentially deepening its presence and clinical relationships across the US hearing-care ecosystem.\nWe’ll now...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/did-va-access-to-nucleus-nexa-implants-just-shift-cochlears","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/did-va-access-to-nucleus-nexa-implants-just-shift-cochlears","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602566675","title":"Investors Shouldn't Overlook Cochlear's (ASX:COH) Impressive Returns On Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2602566675","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602566675?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:00","pubTimestamp":1768168824,"startTime":"0","endTime":"0","summary":"If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/investors-shouldnt-overlook-cochlears-asxcoh-impressive-retu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/investors-shouldnt-overlook-cochlears-asxcoh-impressive-retu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EBIT","BK7007","BK4211","COH.AU","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601036471","title":"Cochlear Ltd. Expands Access to Nucleus Nexa System for US Veterans","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036471","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036471?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:16","pubTimestamp":1767878172,"startTime":"0","endTime":"0","summary":"Cochlear Ltd., the global leader in implantable hearing solutions, has announced the availability of its groundbreaking Nucleus Nexa System for eligible US military veterans at VA clinics nationwide. This expansion provides veterans with access to Cochlear's most advanced hearing technologies, reflecting the company’s commitment to supporting those who have served. By offering the Nucleus Nexa System through VA clinics, Cochlear is broadening the reach of its innovative solutions and strengthening its mission to help more people with hearing loss.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cochlear Ltd. published the original content used to generate this news brief via PR Newswire  on January 08, 2026, and is solely responsible fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL2tXHZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594544407","title":"Declining Stock and Solid Fundamentals: Is The Market Wrong About Cochlear Limited (ASX:COH)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594544407","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594544407?lang=en_us&edition=fundamental","pubTime":"2025-12-25 04:01","pubTimestamp":1766606491,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 8.2...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/declining-stock-and-solid-fundamentals-is-the-market-wrong-a-1772","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/declining-stock-and-solid-fundamentals-is-the-market-wrong-a-1772","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592418950","title":"BUZZ-Morningstar sees Australia's Cochlear shares as slightly overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2592418950","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592418950?lang=en_us&edition=fundamental","pubTime":"2025-12-19 03:59","pubTimestamp":1766087986,"startTime":"0","endTime":"0","summary":"BUZZ-Morningstar sees Australia's Cochlear shares as slightly overvalued** Morningstar analysts see shares of Australia's Cochlear COH.AX as slightly overvalued as market extrapolates high cochlear unit sales** Investment research firm expects revenue growth for hearing implant maker to moderate as average selling prices decline, given mix shift to lower-price emerging markets** Says demand for Cochlear's sound processor upgrades softening with patients delaying upgrades due to cost-of-living pressures and satisfaction with older sound processors** Notes next-largest competitor, Med- El, is also winning market share with its new sound processor offering, Sonnet 3** Average rating of 15 analysts is \"hold\"; their median PT is A$299.77 – according to data compiled by LSEG ** Stock down nearly 11% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL4N3XO1J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589166878","title":"Recent 3.4% pullback isn't enough to hurt long-term Cochlear (ASX:COH) shareholders, they're still up 45% over 5 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2589166878","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589166878?lang=en_us&edition=fundamental","pubTime":"2025-12-07 06:01","pubTimestamp":1765058487,"startTime":"0","endTime":"0","summary":"Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/recent-34-pullback-isnt-enough-to-hurt-long-term-cochlear-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/recent-34-pullback-isnt-enough-to-hurt-long-term-cochlear-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586299378","title":"Alan Kohler: The grass is always greener on the other side","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299378","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299378?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:30","pubTimestamp":1764203407,"startTime":"0","endTime":"0","summary":"Investors are hardwired to compare themselves with whatever is running hottest at the time. When US tech stocks roar, the temptation is to look at the ASX and wonder why we bother. Yet Alan Kohler, one of the most recognisable voices in Australian finance, is entirely at ease with the slower and steadier returns on home soil. And after decades watching market cycles come and go, he has a simple message for anyone feeling twitchy about missing out.“We probably shouldn’t get too greedy,” he says.The local market has delivered a modest gain this year, but once you factor in dividends, total returns are north of 7 percent with a month still to run.It feels unremarkable only when stacked against the US, where the S&P 500 has surged on the back of an AI-fuelled boom. But Kohler’s view is that the extra sizzle in the US comes with baggage that many investors tend to forget until it is too late.Nvidia continues to deliver big numbers, but the market is slowly realising that its customer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/alan-kohler-the-grass-is-always-greener-on-the-other-side","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/alan-kohler-the-grass-is-always-greener-on-the-other-side","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU2125909247.SGD","SNVD.UK","NVDY","LU2413666699.HKD","LU1066051498.USD","NVD2.UK","3NVD.UK","LU0689626769.HKD","LU2473716301.USD","BK4579","LU1815333072.USD","LU2750360641.GBP","CSL.AU","LU0466842654.USD","COH.AU","IE00BDCRKT87.USD","XAO.AU","NVD3.UK","NVDU","LU0683600562.USD","LU0342679015.USD","BK7508","NVD","LU1868836591.USD","LU1935043023.USD","LMG.AU","LU2244417387.USD","NVDS","BK4554","LU2592432038.USD","XJO.AU","RMD.AU","LU0345770308.USD","NVDD","NVIW.SI","SRL.AU","NVDS.UK","LU2108987350.USD","LU1267930730.SGD","LU1116320737.USD","NVDA","2NVD.UK","LU0203202063.USD","LU1551013342.USD","ARU.AU","LU1934455277.USD","XKO.AU","BK4567"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2584965029","title":"Risks To Shareholder Returns Are Elevated At These Prices For Cochlear Limited (ASX:COH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584965029","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584965029?lang=en_us&edition=fundamental","pubTime":"2025-11-19 04:41","pubTimestamp":1763498508,"startTime":"0","endTime":"0","summary":"When close to half the companies in Australia have price-to-earnings ratios (or \"P/E's\") below 21x, you may consider...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/risks-to-shareholder-returns-are-elevated-at-these-prices-fo-734","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/risks-to-shareholder-returns-are-elevated-at-these-prices-fo-734","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580200444","title":"Cochlear Limited (ASX:COH) is favoured by institutional owners who hold 57% of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=2580200444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580200444?lang=en_us&edition=fundamental","pubTime":"2025-11-01 07:04","pubTimestamp":1761951846,"startTime":"0","endTime":"0","summary":"Key Insights Institutions' substantial holdings in Cochlear implies that they have significant influence over the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-limited-asxcoh-is-favoured-by-institutional-owners-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-limited-asxcoh-is-favoured-by-institutional-owners-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}]}}